After reconstitution, a methylcobalamin-containing solution loses potency faster than cyanocobalamin
Letrozole has a longer half-life (approximately 4 days) and reaches steady-state plasma concentrations over a longer period (60 days) ( Recent clinical publications have highlighted the dermatologic toxicities induced by aromatase inhibitors (AIs) ( Alopecia is particularly common in BC patients treated with AIs, with a notable incidence among AEs ( Our analysis found positive signals for onychoclasis, vascular responses (e.g., hypersensitivity vasculitis, vascular purpura), hair abnormalities (e.g., alopecia, androgenetic alopecia, hair growth abnormality), and nail toxicity (e.g., nail disorder, discoloration, nail dystrophy) across all three AIs, indicating a need for appropriate patient care
Secondary outcomes A comparison of secondary outcomes between the SGLT2i and GLP1-RA groups was presented in Table 3
Menopause is linked to weight gainespecially belly weight gain that can have negative health consequences
The results will be visible somewhere between six to eight weeks post-treatment